▶ 調査レポート

直接経口抗凝固剤の世界市場レポート2020

• 英文タイトル:Global Direct Oral Anticoagulant Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。直接経口抗凝固剤の世界市場レポート2020 / Global Direct Oral Anticoagulant Sales Market Report 2020 / QY20ST-06902資料のイメージです。• レポートコード:QY20ST-06902
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥580,000 (USD4,000)▷ お問い合わせ
  Multi User¥870,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,160,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の直接経口抗凝固剤市場について種類別(アピキサバン、ダビガトラン、リバロキサバン、エドキサバン)、用途別(病院薬局、ドラッグストア、オンライン薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・直接経口抗凝固剤市場の概要
・世界の主要地域別直接経口抗凝固剤市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の直接経口抗凝固剤市場規模2015-2026:種類別(アピキサバン、ダビガトラン、リバロキサバン、エドキサバン)
・世界の直接経口抗凝固剤市場規模2015-2026:用途別(病院薬局、ドラッグストア、オンライン薬局)
・直接経口抗凝固剤の北米市場規模2015-2020
・直接経口抗凝固剤のヨーロッパ市場規模2015-2020
・直接経口抗凝固剤の中国市場規模2015-2020
・直接経口抗凝固剤の日本市場規模2015-2020
・直接経口抗凝固剤の東南アジア市場規模2015-2020
・直接経口抗凝固剤のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・直接経口抗凝固剤の製造コスト分析
・販売チャネル、流通業者、顧客
・直接経口抗凝固剤の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Direct Oral Anticoagulant Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Direct Oral Anticoagulant market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Direct Oral Anticoagulants are rapid and short acting agents which have relatively low bleeding risks and overall safety. Direct oral anticoagulants are alternative choice for blood clot treatment in selected patients.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Direct Oral Anticoagulant market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Direct Oral Anticoagulant industry.
Based on our recent survey, we have several different scenarios about the Direct Oral Anticoagulant YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Direct Oral Anticoagulant will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Direct Oral Anticoagulant market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Direct Oral Anticoagulant market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Direct Oral Anticoagulant market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Direct Oral Anticoagulant market. The report also includes nautical information, where it shows Direct Oral Anticoagulant market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Direct Oral Anticoagulant market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Direct Oral Anticoagulant market.
Geographical Analysis:
Based on region, the global Direct Oral Anticoagulant market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Direct Oral Anticoagulant market are
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
Segment by Type
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Segment by Application
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Direct Oral Anticoagulant market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Direct Oral Anticoagulant market.
• The market share of the global Direct Oral Anticoagulant market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Direct Oral Anticoagulant market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Direct Oral Anticoagulant market.

レポート目次

1 Direct Oral Anticoagulant Market Overview
1.1 Direct Oral Anticoagulant Product Scope
1.2 Direct Oral Anticoagulant Segment by Type
1.2.1 Global Direct Oral Anticoagulant Sales by Type (2020-2026)
1.2.2 Apixaban
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Edoxaban
1.3 Direct Oral Anticoagulant Segment by Application
1.3.1 Global Direct Oral Anticoagulant Sales Comparison by Application (2020-2026)
1.3.2 Hospitals Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Direct Oral Anticoagulant Market Estimates and Forecasts (2015-2026)
1.4.1 Global Direct Oral Anticoagulant Sales Growth Rate (2015-2026)
1.4.2 Global Direct Oral Anticoagulant Revenue and Growth Rate (2015-2026)
1.4.3 Global Direct Oral Anticoagulant Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Direct Oral Anticoagulant Industry Impact
1.5.1 How the Covid-19 is Affecting the Direct Oral Anticoagulant Industry
1.5.1.1 Direct Oral Anticoagulant Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Direct Oral Anticoagulant Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Direct Oral Anticoagulant Players to Combat Covid-19 Impact

2 Direct Oral Anticoagulant Estimate and Forecast by Region
2.1 Global Direct Oral Anticoagulant Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Direct Oral Anticoagulant Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Direct Oral Anticoagulant Sales Market Share by Region (2015-2020)
2.2.2 Global Direct Oral Anticoagulant Revenue Market Share by Region (2015-2020)
2.3 Global Direct Oral Anticoagulant Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Direct Oral Anticoagulant Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Direct Oral Anticoagulant Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Direct Oral Anticoagulant Estimates and Projections (2015-2026)
2.4.2 Europe Direct Oral Anticoagulant Estimates and Projections (2015-2026)
2.4.3 China Direct Oral Anticoagulant Estimates and Projections (2015-2026)
2.4.4 Japan Direct Oral Anticoagulant Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Direct Oral Anticoagulant Estimates and Projections (2015-2026)
2.4.6 India Direct Oral Anticoagulant Estimates and Projections (2015-2026)
3 Global Direct Oral Anticoagulant Competition Landscape by Players
3.1 Global Top Direct Oral Anticoagulant Players by Sales (2015-2020)
3.2 Global Top Direct Oral Anticoagulant Players by Revenue (2015-2020)
3.3 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct Oral Anticoagulant as of 2019)
3.4 Global Direct Oral Anticoagulant Average Price by Company (2015-2020)
3.5 Manufacturers Direct Oral Anticoagulant Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Direct Oral Anticoagulant Players (Opinion Leaders)
4 Global Direct Oral Anticoagulant Market Size by Type
4.1 Global Direct Oral Anticoagulant Historic Market Review by Type (2015-2020)
4.1.1 Global Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
4.1.2 Global Direct Oral Anticoagulant Revenue Market Share by Type (2015-2020)
4.1.3 Global Direct Oral Anticoagulant Price by Type (2014-2020)
4.2 Global Direct Oral Anticoagulant Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Direct Oral Anticoagulant Sales Forecast by Type (2021-2026)
4.2.2 Global Direct Oral Anticoagulant Revenue Forecast by Type (2021-2026)
4.2.3 Global Direct Oral Anticoagulant Price Forecast by Type (2021-2026)
5 Global Direct Oral Anticoagulant Market Size by Application
5.1 Global Direct Oral Anticoagulant Historic Market Review by Application (2015-2020)
5.1.1 Global Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)
5.1.2 Global Direct Oral Anticoagulant Revenue Market Share by Application (2015-2020)
5.1.3 Global Direct Oral Anticoagulant Price by Application (2015-2020)
5.2 Global Direct Oral Anticoagulant Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Direct Oral Anticoagulant Sales Forecast by Application (2021-2026)
5.2.2 Global Direct Oral Anticoagulant Revenue Forecast by Application (2021-2026)
5.2.3 Global Direct Oral Anticoagulant Price Forecast by Application (2021-2026)

3 North America Direct Oral Anticoagulant Market Facts & Figures
3.2 North America Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
3.3 North America Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
3.4 North America Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

4 Europe Direct Oral Anticoagulant Market Facts & Figures
4.2 Europe Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
4.3 Europe Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
4.4 Europe Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

5 China Direct Oral Anticoagulant Market Facts & Figures
5.2 China Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
5.3 China Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
5.4 China Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

6 Japan Direct Oral Anticoagulant Market Facts & Figures
6.2 Japan Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
6.3 Japan Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
6.4 Japan Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

7 Southeast Asia Direct Oral Anticoagulant Market Facts & Figures
7.2 Southeast Asia Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

8 India Direct Oral Anticoagulant Market Facts & Figures
8.2 India Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
8.3 India Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
8.4 India Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Direct Oral Anticoagulant Business
12.1 Bristol-Meyers Squibb Co
12.1.1 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Corporation Information
12.1.2 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Business Overview and Total Revenue
12.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Products Offered
12.1.5 Bristol-Meyers Squibb Co Recent Development
12.2 Pfizer Inc.
12.2.1 Pfizer Inc. Direct Oral Anticoagulant Corporation Information
12.2.2 Pfizer Inc. Direct Oral Anticoagulant Business Overview and Total Revenue
12.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Inc. Direct Oral Anticoagulant Products Offered
12.2.5 Pfizer Inc. Recent Development
12.3 Boehringer Ingelheim Pharmaceuticals, Inc
12.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Corporation Information
12.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Products Offered
12.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Development
12.4 Janssen Pharmaceuticals, Inc.
12.4.1 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Corporation Information
12.4.2 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Business Overview and Total Revenue
12.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Products Offered
12.4.5 Janssen Pharmaceuticals, Inc. Recent Development
12.5 Bayer AG
12.5.1 Bayer AG Direct Oral Anticoagulant Corporation Information
12.5.2 Bayer AG Direct Oral Anticoagulant Business Overview and Total Revenue
12.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer AG Direct Oral Anticoagulant Products Offered
12.5.5 Bayer AG Recent Development
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Corporation Information
12.6.2 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Business Overview and Total Revenue
12.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Products Offered
12.6.5 Teva Pharmaceutical Industries Ltd Recent Development
12.7 Pab Organics Private Limited
12.7.1 Pab Organics Private Limited Direct Oral Anticoagulant Corporation Information
12.7.2 Pab Organics Private Limited Direct Oral Anticoagulant Business Overview and Total Revenue
12.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pab Organics Private Limited Direct Oral Anticoagulant Products Offered
12.7.5 Pab Organics Private Limited Recent Development
12.8 Daiichi Sankyo Company, Limited
12.8.1 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Corporation Information
12.8.2 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Business Overview and Total Revenue
12.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Products Offered
12.8.5 Daiichi Sankyo Company, Limited Recent Development

13 Direct Oral Anticoagulant Manufacturing Cost Analysis
13.1 Direct Oral Anticoagulant Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Direct Oral Anticoagulant
13.4 Direct Oral Anticoagulant Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Direct Oral Anticoagulant Distributors List
14.3 Direct Oral Anticoagulant Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Direct Oral Anticoagulant Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Direct Oral Anticoagulant Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Direct Oral Anticoagulant Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Direct Oral Anticoagulant Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Direct Oral Anticoagulant Players to Combat Covid-19 Impact
Table 8. Global Market Direct Oral Anticoagulant Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Direct Oral Anticoagulant Sales (MT) by Region (2015-2020)
Table 10. Global Direct Oral Anticoagulant Sales Market Share by Region (2015-2020)
Table 11. Global Direct Oral Anticoagulant Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Direct Oral Anticoagulant Revenue Share by Region (2015-2020)
Table 13. Global Direct Oral Anticoagulant Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Direct Oral Anticoagulant Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Direct Oral Anticoagulant Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Direct Oral Anticoagulant Revenue Share Forecast by Region (2021-2026)
Table 17. Global Direct Oral Anticoagulant (MT) of Key Companies (2015-2020)
Table 18. Global Direct Oral Anticoagulant Sales Share by Company (2015-2020)
Table 19. Global Direct Oral Anticoagulant Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Direct Oral Anticoagulant Revenue Share by Company (2015-2020)
Table 21. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct Oral Anticoagulant as of 2019)
Table 22. Global Direct Oral Anticoagulant Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Direct Oral Anticoagulant Manufacturing Sites and Area Served
Table 24. Manufacturers Direct Oral Anticoagulant Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Direct Oral Anticoagulant Players
Table 27. Global Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 28. Global Direct Oral Anticoagulant Sales Share by Type (2015-2020)
Table 29. Global Direct Oral Anticoagulant Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Direct Oral Anticoagulant Price (MT) by Type (2015-2020)
Table 31. Global Direct Oral Anticoagulant Sales Share by Type (2021-2026)
Table 32. Global Direct Oral Anticoagulant Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Direct Oral Anticoagulant Revenue Share by Type (2021-2026)
Table 34. Global Direct Oral Anticoagulant Price (MT) by Type (2021-2026)
Table 35. Global Direct Oral Anticoagulant Sales (MT) by Application (2015-2020)
Table 36. Global Direct Oral Anticoagulant Sales Share by Application (2015-2020)
Table 37. Global Direct Oral Anticoagulant Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Direct Oral Anticoagulant Price (MT) by Application (2015-2020)
Table 39. Global Direct Oral Anticoagulant Sales (MT) by Application (2021-2026)
Table 40. Global Direct Oral Anticoagulant Sales Share by Application (2021-2026)
Table 41. Global Direct Oral Anticoagulant Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Direct Oral Anticoagulant Revenue Share by Application (2021-2026)
Table 43. Global Direct Oral Anticoagulant Price (MT) by Application (2021-2026)
Table 44. United States Direct Oral Anticoagulant Sales (MT) by Company (2015-2020)
Table 45. United States Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
Table 46. United States Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 47. United States Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 48. United States Direct Oral Anticoagulant Sales (MT) by Application (2015-2020)
Table 49. United States Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)
Table 50. Europe Direct Oral Anticoagulant Sales (MT) by Company (2015-2020)
Table 51. Europe Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
Table 52. Europe Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 53. Europe Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 54. Europe Direct Oral Anticoagulant Sales (MT) by Application (2015-2020)
Table 55. Europe Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 56. China Direct Oral Anticoagulant Sales (MT) by Company (2015-2020)
Table 57. China Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
Table 58. China Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 59. China Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 60. China Direct Oral Anticoagulant Sales (MT) by Application (2015-2020)
Table 61. China Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)
Table 62. Japan Direct Oral Anticoagulant Sales (MT) by Company (2015-2020)
Table 63. Japan Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
Table 64. Japan Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 65. Japan Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 66. Japan Direct Oral Anticoagulant Sales (MT) by Application (2015-2020)
Table 67. Japan Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Direct Oral Anticoagulant Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)
Table 74. India Direct Oral Anticoagulant Sales (MT) by Company (2015-2020)
Table 75. India Direct Oral Anticoagulant Sales Market Share by Company (2015-2020)
Table 76. India Direct Oral Anticoagulant Sales (MT) by Type (2015-2020)
Table 77. India Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)
Table 78. India Direct Oral Anticoagulant Sales (MT) by Application (2015-2020)
Table 79. India Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)
Table 80. Bristol-Meyers Squibb Co Corporation Information
Table 81. Bristol-Meyers Squibb Co Description and Business Overview
Table 82. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product
Table 84. Bristol-Meyers Squibb Co Recent Development
Table 85. Pfizer Inc. Corporation Information
Table 86. Pfizer Inc. Description and Business Overview
Table 87. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Pfizer Inc. Direct Oral Anticoagulant Product
Table 89. Pfizer Inc. Recent Development
Table 90. Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
Table 91. Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview
Table 92. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product
Table 94. Boehringer Ingelheim Pharmaceuticals, Inc Recent Development
Table 95. Janssen Pharmaceuticals, Inc. Corporation Information
Table 96. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 97. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product
Table 99. Janssen Pharmaceuticals, Inc. Recent Development
Table 100. Bayer AG Corporation Information
Table 101. Bayer AG Description and Business Overview
Table 102. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Bayer AG Direct Oral Anticoagulant Product
Table 104. Bayer AG Recent Development
Table 105. Teva Pharmaceutical Industries Ltd Corporation Information
Table 106. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 107. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product
Table 109. Teva Pharmaceutical Industries Ltd Recent Development
Table 110. Pab Organics Private Limited Corporation Information
Table 111. Pab Organics Private Limited Description and Business Overview
Table 112. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Pab Organics Private Limited Direct Oral Anticoagulant Product
Table 114. Pab Organics Private Limited Recent Development
Table . Daiichi Sankyo Company, Limited Corporation Information
Table . Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Daiichi Sankyo Company, Limited Description and Business Overview
Table . Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product
Table . Daiichi Sankyo Company, Limited Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Direct Oral Anticoagulant Distributors List
Table 123. Direct Oral Anticoagulant Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Direct Oral Anticoagulant Product Picture
Figure 2. Global Direct Oral Anticoagulant Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Direct Oral Anticoagulant Market Share by Application in 2020 & 2026
Figure 6. Hospitals Pharmacies Examples
Figure 7. Drug Stores Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Direct Oral Anticoagulant Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Direct Oral Anticoagulant Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Direct Oral Anticoagulant Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Direct Oral Anticoagulant Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Direct Oral Anticoagulant Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Direct Oral Anticoagulant Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Direct Oral Anticoagulant Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Direct Oral Anticoagulant Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Direct Oral Anticoagulant Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Direct Oral Anticoagulant Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Direct Oral Anticoagulant Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Direct Oral Anticoagulant Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Direct Oral Anticoagulant Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Direct Oral Anticoagulant Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Direct Oral Anticoagulant Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Direct Oral Anticoagulant Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Direct Oral Anticoagulant Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Direct Oral Anticoagulant Players Market Share by Revenue in Direct Oral Anticoagulant 2015 & 2019
Figure 27. Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Direct Oral Anticoagulant Revenue Share by Type (2015-2020)
Figure 29. Global Direct Oral Anticoagulant Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Direct Oral Anticoagulant Revenue Share by Application (2015-2020)
Figure 31. Global Direct Oral Anticoagulant Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 33. United States Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 34. Europe Direct Oral Anticoagulant Sales Market Share by Company in 2019
Figure 35. Europe Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 36. Europe Direct Oral Anticoagulant Sales Market Share by Application in 2019
Figure 37. China Direct Oral Anticoagulant Sales Market Share by Company in 2019
Figure 38. China Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 39. China Direct Oral Anticoagulant Sales Market Share by Application in 2019
Figure 40. Japan Direct Oral Anticoagulant Sales Market Share by Company in 2019
Figure 41. Japan Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 42. Japan Direct Oral Anticoagulant Sales Market Share by Application in 2019
Figure 43. Southeast Asia Direct Oral Anticoagulant Sales Market Share by Company in 2019
Figure 44. Southeast Asia Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 45. Southeast Asia Direct Oral Anticoagulant Sales Market Share by Application in 2019
Figure 46. India Direct Oral Anticoagulant Sales Market Share by Company in 2019
Figure 47. India Direct Oral Anticoagulant Sales Market Share by Type in 2019
Figure 48. India Direct Oral Anticoagulant Sales Market Share by Application in 2019
Figure 49. Bristol-Meyers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boehringer Ingelheim Pharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Janssen Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Pab Organics Private Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Daiichi Sankyo Company, Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Direct Oral Anticoagulant
Figure 59. Manufacturing Process Analysis of Direct Oral Anticoagulant
Figure 60. Direct Oral Anticoagulant Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed